Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in Macau Dec 12, 2024 12:11 HKT/SGT Read More
Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia Dec 11, 2024 13:45 HKT/SGT Read More
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China Dec 09, 2024 14:00 JST Read More
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China Dec 09, 2024 13:00 HKT/SGT Read More
Sweetness Affecting Both the Young and Old: Prevent Diabetes with LAC This World Diabetes Day Dec 04, 2024 14:30 HKT/SGT Read More
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy Dec 04, 2024 11:08 HKT/SGT Read More
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia Dec 02, 2024 22:30 JST Read More
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia Dec 02, 2024 21:30 HKT/SGT Read More
Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong Dec 02, 2024 10:34 HKT/SGT Read More
Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate Nov 30, 2024 21:08 HKT/SGT Read More